Evidence map›Paper›PMID 37819462›Full record

ArticleJournal of neurology2024

Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis.

Veronica Ravano, Gian Franco Piredda, Jan Krasensky, Michaela Andelova, Tomas Uher, Barbora Srpova, Eva Kubala Havrdova, Karolina Vodehnalova, Dana Horakova, Petra Nytrova and 7 more

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Veronica RavanoAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland. veronica.ravano@epfl.ch.ORCID http://orcid.org/0000-0002-1532-9664
Gian Franco PireddaAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-8449-6634
Jan KrasenskyDepartment of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-5605-8821
Michaela AndelovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-3812-7483
Tomas UherDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-3160-9022
Barbora SrpovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-8092-6625
Eva Kubala HavrdovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-9543-4359
Karolina VodehnalovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-0675-2866
Dana HorakovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-1915-0036
Petra NytrovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-4885-602X
Jonathan A DisselhorstAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-2924-1866
Tom HilbertAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-8207-4908
Bénédicte MaréchalAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-7866-2854
Jean-Philippe ThiranDepartment of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-2938-9657
Tobias KoberAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.ORCID http://orcid.org/0000-0001-7598-9456
Jonas RichiardiDepartment of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-6975-5634
Manuela VaneckovaDepartment of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-8784-7997

Funding

Charles University and General University Hospital in Prague RVO VFN 64165Czech Ministry of Education Project Cooperation LF1 - reasearch area NeuroscienceCzech Ministry of Health NU 22-04-00193Roche NTC03706118
6 · The paper itself

Abstract

objectivesMicrostructural characterization of patients with multiple sclerosis (MS) has been shown to correlate better with disability compared to conventional radiological biomarkers. Quantitative MRI provides effective means to characterize microstructural brain tissue changes both in lesions and normal-appearing brain tissue. However, the impact of the location of microstructural alterations in terms of neuronal pathways has not been thoroughly explored so far. Here, we study the extent and the location of tissue changes probed using quantitative MRI along white matter (WM) tracts extracted from a connectivity atlas.

methodsWe quantified voxel-wise T1 tissue alterations compared to normative values in a cohort of 99 MS patients. For each WM tract, we extracted metrics reflecting tissue alterations both in lesions and normal-appearing WM and correlated these with cross-sectional disability and disability evolution after 2 years.

resultsIn early MS patients, T1 alterations in normal-appearing WM correlated better with disability evolution compared to cross-sectional disability. Further, the presence of lesions in supratentorial tracts was more strongly associated with cross-sectional disability, while microstructural alterations in infratentorial pathways yielded higher correlations with disability evolution. In progressive patients, all major WM pathways contributed similarly to explaining disability, and correlations with disability evolution were generally poor.

conclusionsWe showed that microstructural changes evaluated in specific WM pathways contribute to explaining future disability in early MS, hence highlighting the potential of tract-wise analyses in monitoring disease progression. Further, the proposed technique allows to estimate WM tract-specific microstructural characteristics in clinically compatible acquisition times, without the need for advanced diffusion imaging.

Indexed as

Multiple SclerosisWhite MatterBrainCross-Sectional StudiesHumansMagnetic Resonance ImagingDemyelinating diseasesMagnetic resonance imagingMultiple sclerosisRelaxometryWhite matter

Identifiers

PMID37819462
PMCPMC10827809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.